YU59502A - Dobijanje dialkilpiridilborana - Google Patents

Dobijanje dialkilpiridilborana

Info

Publication number
YU59502A
YU59502A YU59502A YUP59502A YU59502A YU 59502 A YU59502 A YU 59502A YU 59502 A YU59502 A YU 59502A YU P59502 A YUP59502 A YU P59502A YU 59502 A YU59502 A YU 59502A
Authority
YU
Yugoslavia
Prior art keywords
preparation
threealkylborane
greenyard
reagent
dialkylpyridylboranes
Prior art date
Application number
YU59502A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
David Harold Brown Ripin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU59502A publication Critical patent/YU59502A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU59502A 2001-08-27 2002-08-09 Dobijanje dialkilpiridilborana YU59502A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31518301P 2001-08-27 2001-08-27

Publications (1)

Publication Number Publication Date
YU59502A true YU59502A (sh) 2004-12-31

Family

ID=23223262

Family Applications (1)

Application Number Title Priority Date Filing Date
YU59502A YU59502A (sh) 2001-08-27 2002-08-09 Dobijanje dialkilpiridilborana

Country Status (18)

Country Link
US (1) US6570017B2 (https=)
EP (1) EP1288217B1 (https=)
JP (1) JP2003096084A (https=)
KR (1) KR20030019112A (https=)
CN (1) CN1401649A (https=)
AT (1) ATE321766T1 (https=)
BR (1) BR0203371A (https=)
CA (1) CA2399834C (https=)
CZ (1) CZ20022642A3 (https=)
DE (1) DE60210224T2 (https=)
ES (1) ES2256416T3 (https=)
HU (1) HUP0202868A3 (https=)
IL (1) IL151379A0 (https=)
MX (1) MXPA02008364A (https=)
PL (1) PL355706A1 (https=)
RU (1) RU2002122947A (https=)
YU (1) YU59502A (https=)
ZA (1) ZA200206778B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8648192B2 (en) * 2010-05-26 2014-02-11 Boehringer Ingelheim International Gmbh 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives
CN103483366B (zh) * 2013-09-05 2017-02-08 润泽制药(苏州)有限公司 甲氧基二乙基硼烷的制备方法
US20180370946A1 (en) * 2015-11-17 2018-12-27 Dow Agrosciences Llc 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
CN117402184B (zh) * 2023-12-15 2024-04-26 山东国邦药业有限公司 一种二乙基甲氧基硼烷的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010947B1 (en) * 1978-11-07 1982-01-13 Imperial Chemical Industries Plc Alkylborane complexes with aromatic amines, solutions thereof for use as hydroborating and reducing agents, and processes for their manufacture
GB8304613D0 (en) * 1983-02-18 1983-03-23 Ici Plc Chemical process
DE4320432A1 (de) * 1993-06-21 1994-12-22 Bayer Ag Substituierte Mono- und Bipyridylmethylderivate
US5486534A (en) * 1994-07-21 1996-01-23 G. D. Searle & Co. 3,4-substituted pyrazoles for the treatment of inflammation
CA2329065A1 (en) * 1998-05-05 1999-11-11 Francisco Xavier Talamas Pyrazole derivatives as p-38 map kinase inhibitors

Also Published As

Publication number Publication date
DE60210224D1 (de) 2006-05-18
US20030083312A1 (en) 2003-05-01
PL355706A1 (en) 2003-03-10
CZ20022642A3 (cs) 2003-09-17
CA2399834A1 (en) 2003-02-27
JP2003096084A (ja) 2003-04-03
KR20030019112A (ko) 2003-03-06
ZA200206778B (en) 2004-02-23
BR0203371A (pt) 2003-05-27
DE60210224T2 (de) 2007-01-11
CN1401649A (zh) 2003-03-12
ES2256416T3 (es) 2006-07-16
CA2399834C (en) 2006-08-22
EP1288217A2 (en) 2003-03-05
US6570017B2 (en) 2003-05-27
HUP0202868A2 (hu) 2003-06-28
EP1288217A3 (en) 2003-09-17
HU0202868D0 (https=) 2002-10-28
EP1288217B1 (en) 2006-03-29
IL151379A0 (en) 2003-04-10
RU2002122947A (ru) 2004-03-10
MXPA02008364A (es) 2003-03-04
HUP0202868A3 (en) 2004-04-28
ATE321766T1 (de) 2006-04-15

Similar Documents

Publication Publication Date Title
WO2005014035A3 (en) Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
MXPA03008754A (es) Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor.
WO2004074244A3 (en) Pyrimidine compounds
WO2003093269A3 (de) Substituierte pyrazolo-pyrimidin-4-one
HK1048632A1 (zh) 雜環取代的吡唑啉酮化合物
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
WO2002048147A3 (en) Pyrazolopyridines
WO2003016282A3 (en) Substituted 1h-dihydropyrazoles, their preparation and use
WO2003048301A3 (en) Anti-hla-dr antibodies and the methods of using thereof
DE60125734D1 (en) Neue aryl fructose-1,6-bisphosphatase inhibitoren
WO2003059903A3 (de) Substituierte 4-aminopyridin-derivate als schädlingsbekämpfungsmittel
TW200616960A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
WO2005009951A3 (en) Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
WO2004007664A3 (en) Nucleic acid vectors
WO2001032935A3 (en) Molecular microarrays and methods for production and use thereof
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
WO2005000207A3 (en) Pcdgf receptor antibodies and methods of use thereof
YU59502A (sh) Dobijanje dialkilpiridilborana
AU2002248531A1 (en) Pyrazolopyriadine derivatives
WO2003024400A3 (en) Process for the preparation of 1,5-diarylpyrazoles
CA2270301A1 (en) Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for their preparation
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
WO2004050834A3 (en) GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER